-
1
Association of Dipeptidiyl Peptidase-4 Inhibitors and Bullose Pemphigoid: A Report of Four Cases
Published 2024-06-01Subjects: Get full text
Article -
2
Novel insight into the formation and inhibition mechanism of dipeptidyl peptidase-Ⅳ inhibitory peptides from fermented mandarin fish (Chouguiyu)
Published 2023-11-01Subjects: Get full text
Article -
3
Identification and dipeptidyl peptidase IV (DPP-IV) inhibitory activity verification of peptides from mouse lymphocytes
Published 2022-11-01Subjects: “…Dipeptidyl peptidase IV (DPP-IV) inhibitory activity…”
Get full text
Article -
4
Expert Opinion on Fixed Dose Combination of Dapagliflozin Plus Sitagliptin for Unmet Cardiovascular Benefits in Type 2 Diabetes Mellitus
Published 2024-04-01Subjects: Get full text
Article -
5
Diabetes Treatment with Dapagliflozin and Its Combinations: Insights from Clinical Practice
Published 2024-04-01Subjects: Get full text
Article -
6
-
7
Screening and evaluation of novel DPP-IV inhibitory peptides in goat milk based on molecular docking and molecular dynamics simulation
Published 2025-01-01Subjects: Get full text
Article -
8
Τhiazolidine-4-One Derivatives with Variable Modes of Inhibitory Action Against DPP4, a Drug Target with Multiple Activities and Established Role in Diabetes Mellitus Type II
Published 2025-01-01Subjects: “…DPP4…”
Get full text
Article -
9
CADD based designing and biological evaluation of novel triazole based thiazolidinedione coumarin hybrids as antidiabetic agent
Published 2025-02-01Subjects: Get full text
Article -
10
Sitagliptin: a potential drug for the treatment of COVID-19?
Published 2021-06-01Subjects: Get full text
Article -
11
The Application of Incretin-Based Pharmacotherapy in the Contemporary Management of Type 2 Diabetes: A Review of the Literature
Published 2025-01-01Subjects: Get full text
Article